NLM Logo

Clinical Trial, Phase III MeSH Descriptor Data 2024

MeSH Heading
Clinical Trial, Phase III
Tree Number(s)
Unique ID
RDF Unique Identifier
this heading is used as a Publication Type; for original report of the conduct or results of a specific phase III clinical trial; a different heading CLINICAL TRIALS, PHASE III AS TOPIC is used for general design, methodology, economics, etc. of Phase III clinical trials.
Scope Note
Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the United States or a foreign country.
Entry Term(s)
Clinical Trial, Phase 3
History Note
Date Established
Date of Entry
Revision Date

No Qualifiers
Clinical Trial, Phase III Preferred
page delivered in 0.142s